Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.6.6 was added to the history and the previous revision v3.6.5 was removed from the visible list. This updates the versioning record for the page without modifying the study data or status.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history now shows the current page revision as v3.6.5, replacing the previous v3.6.4. This is a metadata update indicating the page was refreshed to the latest version.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry (v3.6.4) was added to the history, representing an update to the study record. The previous revision (v3.6.3) was removed from the change log.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry (v3.6.3) was added to the history, and the previous revision (v3.6.2) was removed from the current listing, updating the page's version history.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry v3.6.2 was added to the history, and the previous entry v3.6.0 was removed, updating the study's submission record.SummaryDifference0.1%

- Check91 days agoChange DetectedThe history now shows recruitment status updated to no longer looking for participants and a new Revision: v3.6.0 added, replacing the previous Revision: v3.5.5.SummaryDifference0.3%

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.